A new study published in JAMA investigated how various treatment interventions affected long-term outcomes in critically ill patients with COVID-19.

Olivia C. Welter, PharmD

Hydroxychloroquine and the risk for incident retinopathy.

On January 4, 2023, APhA hosted an open forum as part of the Pulse on Practice and Policy Open Forum Series to discuss the drug shortages that pharmacies are facing nationwide

Morgan Carson-Marino, PharmD, MS

Cardiovascular disease (CVD) is a significant global health issue.

Corey Diamond, PharmD

Over the course of the pandemic, researchers raced to find effective treatments for patients with COVID-19.

Lauren Howell, PharmD